GI Bleed Differential Diagnosis: A Comprehensive Guide for Automotive Repair Experts

Gastrointestinal (GI) bleeding is a critical medical condition categorized broadly into upper and lower sources, demarcated by the ligament of Treitz, also known as the suspensory ligament of the duodenum. This anatomical landmark, a peritoneal structure suspending the duodenojejunal flexure from the retroperitoneum, is crucial in differentiating the origin of bleeding. Bleeding proximal to the ligament typically manifests as hematemesis or melena, whereas distal bleeding commonly presents as hematochezia. This article provides a detailed overview of the differential diagnosis of GI bleeding, essential for automotive repair experts seeking to understand this medical emergency.

Objectives:

• To explore the broad spectrum of conditions included in the Gi Bleed Differential Diagnosis.
• To outline the diagnostic approaches for differentiating between various causes of upper and lower GI bleeding.
• To emphasize the importance of recognizing key indicators for accurate differential diagnosis in GI bleeding.
• To promote effective strategies for healthcare professionals in managing patients based on differential diagnosis of GI bleeding.

Access free multiple choice questions on this topic.

Introduction

Gastrointestinal bleeding, a significant clinical challenge, is broadly classified based on its origin relative to the ligament of Treitz. Upper GI bleeds originate proximal to this ligament, often presenting as hematemesis, the vomiting of blood or blood-mixed gastric contents, or melena, characterized by dark, tarry stools with a distinct odor due to hemoglobin digestion. Lower GI bleeds, originating distally, typically manifest as hematochezia, the passage of bright red blood per rectum. Understanding the nuanced differential diagnosis is paramount for effective management and targeted treatment strategies in GI bleeding.

Etiology of Gastrointestinal Bleeding: A Differential Diagnosis Approach

The etiology of GI bleeding is diverse, necessitating a comprehensive differential diagnosis to pinpoint the exact cause. The causes are broadly categorized into upper and lower gastrointestinal bleeding.

Upper GI Bleeding Differential Diagnosis

• Peptic Ulcer Disease: Ulcers in the stomach or duodenum, often due to Helicobacter pylori infection, NSAID use, or acid hypersecretion, are a leading cause. The differential diagnosis must consider both gastric and duodenal ulcers, and factors contributing to their formation.
• Esophagitis: Inflammation of the esophagus, frequently caused by gastroesophageal reflux disease (GERD), infections, or medications. Differential diagnosis needs to distinguish between reflux esophagitis, infectious esophagitis (e.g., Candida, Herpes), and pill-induced esophagitis.
• Gastritis and Duodenitis: Inflammation of the stomach and duodenum lining, respectively, which can be erosive or non-erosive. Differential diagnosis involves considering infectious (e.g., H. pylori), chemical (NSAIDs, alcohol), and autoimmune causes.
• Varices: Esophageal and gastric varices, typically secondary to portal hypertension in liver cirrhosis, are critical in the differential diagnosis of upper GI bleeds, often presenting with massive hematemesis.
• Portal Hypertensive Gastropathy (PHG): Diffuse mucosal changes in the stomach due to portal hypertension, distinct from varices but also a significant cause of bleeding. The differential diagnosis should differentiate PHG from other causes of gastritis.
• Angiodysplasia: Abnormal, fragile blood vessels in the GI tract, more common in the elderly. In the upper GI tract, they are less frequent but should be considered in the differential diagnosis, particularly in cases of obscure bleeding.
• Dieulafoy Lesion: A large, tortuous submucosal artery that erodes through the mucosa without a primary ulcer. Though rare, it should be included in the differential, especially in cases of unexplained upper GI bleeding.
• Gastric Antral Valvular Ectasia (GAVE): Also known as watermelon stomach, characterized by linear stripes of ectatic vessels in the gastric antrum. Distinguished by endoscopic appearance in the differential diagnosis.
• Mallory-Weiss Tears: Longitudinal tears at the gastroesophageal junction, usually due to forceful vomiting or retching. History of vomiting is key in differential diagnosis.
• Cameron Lesions: Linear ulcers within a hiatal hernia at the level of the diaphragm. Should be considered in patients with known hiatal hernias presenting with upper GI bleeding.
• Aortoenteric Fistulas: Abnormal connections between the aorta and the GI tract, often a catastrophic cause of bleeding, typically secondary to aortic graft placement. High index of suspicion is needed in patients with prior aortic surgery.
• Foreign Body Ingestion: Sharp or large foreign bodies can cause mucosal injury and bleeding. History of ingestion is crucial.
• Upper GI Tumors: Gastric or esophageal cancers can present with bleeding. Consider in older patients with alarm symptoms like weight loss, dysphagia.
• Hemobilia: Bleeding from the biliary tract into the duodenum, often post-traumatic or post-surgical. Less common, but important to consider after biliary procedures.
• Hemosuccus Pancreaticus: Bleeding from the pancreatic duct, often due to pancreatitis or pancreatic pseudocysts. Rare cause, consider in patients with pancreatic disease history.

Lower GI Bleeding Differential Diagnosis

• Diverticulosis: Outpouchings in the colon, particularly in the sigmoid colon, are the most common cause of lower GI bleeding. Differential diagnosis should consider segmental colitis associated with diverticulosis (SCAD).
• Angiodysplasia: More common in the right colon in the lower GI tract, frequently seen in older patients. Differential diagnosis includes ruling out other colonic sources in elderly patients.
• Infectious Colitis: Inflammation of the colon due to bacterial (e.g., C. difficile, E. coli O157:H7), viral, or parasitic infections. Stool studies are crucial in the differential diagnosis.
• Ischemic Colitis: Reduced blood flow to the colon, often affecting the splenic flexure. Risk factors like age, cardiovascular disease are important in differential diagnosis.
• Inflammatory Bowel Disease (IBD): Ulcerative colitis and Crohn’s disease. History of chronic diarrhea, abdominal pain, and extraintestinal manifestations aids in differential diagnosis.
• Colon Cancer: Neoplasms in the colon and rectum, especially in older individuals. Alarm symptoms like change in bowel habits, weight loss, and family history are key in differential diagnosis.
• Hemorrhoids: Swollen veins in the rectum and anus, a very common cause of minor rectal bleeding. Differential diagnosis involves distinguishing from more serious causes of hematochezia.
• Anal Fissures: Small tears in the anal mucosa, typically causing pain with bowel movements and bright red rectal bleeding. Clinical examination is usually diagnostic.
• Rectal Varices: Varices in the rectum, similar to esophageal varices, often associated with portal hypertension. Less common than esophageal varices.
• Dieulafoy Lesion: Rare in the lower GI tract but possible. Should be considered in unexplained lower GI bleeding after common causes are excluded.
• Radiation-Induced Colitis: Following radiation therapy to the abdomen or pelvis. History of radiation treatment is crucial in differential diagnosis.

Epidemiology

Upper gastrointestinal bleeding (UGIB) is more prevalent than lower gastrointestinal bleeding (LGIB). The incidence of UGIB is approximately 67 per 100,000 population, while LGIB occurs at about 36 per 100,000 population. LGIB is more frequently observed in men, possibly due to a higher prevalence of vascular diseases and diverticulosis in males. The incidence of both UGIB and LGIB increases with age, although overall incidence rates are showing a decline.

History and Physical Examination in Differential Diagnosis

History

A detailed patient history is crucial for narrowing down the differential diagnosis of GI bleeding. Key historical points include:

• Prior Episodes of GI Bleeding: Recurrent bleeding episodes can suggest conditions like angiodysplasia, varices, or IBD.
• Relevant Past Medical History: Conditions such as liver disease (varices, PHG), peptic ulcer disease, H. pylori infection, diverticulitis, hemorrhoids, and IBD are significant risk factors.
• Comorbid Conditions: Cardiovascular disease, renal disease, and coagulopathies can influence management and risk stratification.
• Medications: NSAIDs, anticoagulants, antiplatelet agents, bismuth, and iron supplements are important to note as they can either cause or exacerbate GI bleeding, or mimic melena.
• Associated Symptoms:
  • Painful vs. Painless Bleeding: Painful bleeding might suggest peptic ulcer disease, ischemic colitis, or anal fissures, while painless bleeding is more typical of diverticulosis, angiodysplasia, or varices.
  • Dysphagia: Difficulty swallowing may point towards esophageal causes like esophagitis or esophageal cancer.
  • Unintentional Weight Loss: Suggestive of malignancy.
  • Preceding Emesis or Retching: Raises suspicion for Mallory-Weiss tears.
  • Change in Bowel Habits: May indicate inflammatory bowel disease or colorectal cancer.

Physical Examination

Physical examination findings are vital for assessing hemodynamic status and guiding differential diagnosis:

• Hemodynamic Instability:
  • Resting tachycardia (heart rate >100 bpm): Suggests mild blood loss (<15% blood volume).
  • Orthostatic hypotension (drop in systolic BP >20 mmHg or diastolic BP >10 mmHg from supine to standing): Indicates moderate blood loss (~15-40% blood volume).
  • Supine hypotension (low blood pressure while lying down): Suggests severe blood loss (>40% blood volume).
• Abdominal Pain: May indicate perforation, ischemia, or inflammatory conditions. Location and nature of pain are important.
• Rectal Examination: Essential for evaluating:
  • Anal fissures
  • Hemorrhoids
  • Anorectal masses (tumors)
  • Stool examination (color and consistency)

Evaluation and Diagnostic Studies for Differential Diagnosis

Laboratory and diagnostic studies are essential to confirm GI bleeding, assess severity, and refine the differential diagnosis.

Laboratory Tests:

• Complete Blood Count (CBC): Hemoglobin and hematocrit levels assess the degree of blood loss.
• International Normalized Ratio (INR), Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT): Evaluate coagulation status, especially important in patients on anticoagulants or with liver disease.
• Lactate: Elevated lactate may indicate tissue hypoperfusion and shock.
• Liver Function Tests (LFTs): Assess liver function, important in patients suspected of variceal bleeding or portal hypertension.

Diagnostic Studies:

• Upper GI Endoscopy (Esophagogastroduodenoscopy – EGD): The gold standard for diagnosing upper GI bleeding. Allows direct visualization and therapeutic intervention for conditions like peptic ulcers, varices, esophagitis, and tumors. Crucial for differential diagnosis in UGIB.
• Lower GI Endoscopy/Colonoscopy: Essential for lower GI bleeding, enabling visualization of the colon and terminal ileum. Diagnostic and therapeutic for conditions like diverticulosis, angiodysplasia, IBD, and colon cancer. Key for differential diagnosis in LGIB.
• Push Enteroscopy and Deep Small Bowel Enteroscopy: Used to visualize the small bowel beyond the duodenum and terminal ileum, useful for diagnosing small bowel sources of bleeding like angiodysplasia or tumors, especially in obscure GI bleeding.
• Nuclear Scintigraphy (Tagged RBC Scan): Detects active bleeding at a rate of 0.1 to 0.5 mL/min. Helpful in localizing bleeding before angiography or surgery, particularly when endoscopy is negative or technically difficult.
• CT Angiography: Identifies actively bleeding vessels and can sometimes suggest the source of bleeding, valuable when endoscopy is non-diagnostic or to guide interventional radiology procedures.
• Standard Angiography: More invasive than CT angiography, but can be both diagnostic and therapeutic, allowing for embolization of bleeding vessels.
• Meckel Scan: Nuclear medicine scan specifically to detect ectopic gastric mucosa, suggestive of Meckel’s diverticulum, a rare cause of lower GI bleeding in younger patients.

Treatment and Management Based on Differential Diagnosis

Acute management of GI bleeding focuses on resuscitation, hemodynamic stabilization, and identifying and treating the underlying cause based on the differential diagnosis.

Risk Stratification:

Risk scores like AIMS65, Rockall, and Oakland scores help assess the severity and prognosis of GI bleeding, guiding decisions on level of care (ICU vs. general ward vs. outpatient).

Setting of Care:

• ICU: For hemodynamically unstable patients, those with ongoing bleeding, or high-risk comorbidities.
• General Medical Ward: For stable patients requiring monitoring and further evaluation.
• Outpatient: Rarely appropriate for active GI bleeding, but may be considered for minor, self-limited bleeding in low-risk individuals after thorough evaluation.

Treatments:

• Supportive Care: NPO, supplemental oxygen, IV access, fluid resuscitation, blood transfusion (RBC, platelets, PCC).
• Medications:
  • PPIs: Empirically used for suspected UGIB, continued or discontinued based on endoscopic findings.
  • Prokinetic Agents: To improve visualization during endoscopy.
  • Vasoactive Medications (e.g., Octreotide): For variceal bleeding.
  • Antibiotics: Prophylactic antibiotics in cirrhotic patients to prevent bacterial translocation.
  • Anticoagulant/Antiplatelet Agents: Temporarily discontinued if possible, reversal considered case-by-case.
• Procedures:
  • NGT Lavage: To clear blood and clots from the stomach before endoscopy.
  • Blakemore/Minnesota Tube: For massive variceal bleeding as a temporizing measure.
  • Endoscopic Therapy: Injection therapy, thermal coagulation, hemostatic clips/bands for various sources in both upper and lower GI bleeds.
  • Angiographic Embolization: For arterial bleeding not controlled endoscopically.
  • Surgery: Reserved for massive, uncontrolled bleeding unresponsive to other measures.

Differential Diagnosis of GI Bleeding: Key Considerations

The differential diagnosis of GI bleeding requires a systematic approach, considering both upper and lower GI sources. Distinguishing between these sources and further differentiating within each category is crucial for targeted management.

Upper GI Bleeding – Key Differentiations:

• Variceal vs. Non-Variceal Bleeding: Crucial distinction in UGIB. History of liver disease, stigmata of cirrhosis, and endoscopic findings are key. Variceal bleeding requires specific therapies like vasoactive drugs and banding.
• Peptic Ulcer vs. Erosive Gastritis/Esophagitis: Endoscopy is essential. Ulcers are discrete mucosal breaks, while gastritis/esophagitis are more diffuse mucosal inflammation. H. pylori testing is important in peptic ulcer disease.
• Mallory-Weiss Tear vs. Dieulafoy Lesion: Mallory-Weiss tears are associated with retching, typically at the GE junction. Dieulafoy lesions are arterial, often found in the proximal stomach, and bleed profusely. Endoscopy is diagnostic.
• Tumor vs. Benign Lesions: Alarm symptoms, patient age, and endoscopic biopsy help differentiate. Tumors may present with strictures, masses, and ulceration.

Lower GI Bleeding – Key Differentiations:

• Diverticular Bleeding vs. Angiodysplasia: Diverticular bleeding is often massive and painless, more common in the sigmoid colon. Angiodysplasia is often chronic or intermittent bleeding, more common in the right colon and cecum, especially in older patients. Colonoscopy is essential for diagnosis.
• IBD vs. Infectious Colitis vs. Ischemic Colitis: History of chronic symptoms, extraintestinal manifestations (IBD), stool studies (infectious colitis), and risk factors for ischemia (ischemic colitis) are important. Colonoscopy with biopsy is often needed for definitive diagnosis.
• Hemorrhoids and Anal Fissures vs. More Proximal Colonic Bleeding: Location of bleeding (rectal vs. mixed with stool), pain with defecation (anal fissures), and clinical examination often differentiate these perianal causes from more proximal colonic sources. Colonoscopy is needed to rule out proximal lesions if bleeding persists or is significant.
• Radiation Colitis vs. Other Colitides: History of pelvic or abdominal radiation is key for radiation colitis. Timeframe post-radiation and endoscopic findings are important in differential diagnosis.

Prognosis

Prognosis following GI bleeding varies depending on the source, patient comorbidities, and management.

For upper GI bleeds, in-hospital mortality is approximately 10%. Long-term mortality remains significant, with 3-year all-cause mortality around 37%. Poorer prognosis is associated with older age, female sex, multiple hospitalizations for GI bleeding, malignancy, and variceal bleeding.

For lower GI bleeds, in-hospital mortality is lower, less than 4%, with death directly from LGIB being rare. Mortality is more often related to comorbid conditions. Increased age, comorbidities, intestinal ischemia, secondary bleeding, coagulopathies, hypovolemia, and transfusion requirements are associated with worse prognosis. Benign causes like hemorrhoids and anal fissures have the best prognosis. Long-term prognosis data for LGIB is less available.

Complications

Untreated or poorly managed GI bleeding can lead to serious complications:

• Respiratory Distress
• Myocardial Infarction
• Infection
• Shock (hypovolemic shock)
• Death

Consultations

Effective management of GI bleeding requires a multidisciplinary team:

• Gastroenterology
• Critical Care
• General Surgery
• Interventional Radiology

Deterrence and Patient Education

Prevention strategies and patient education are crucial in reducing the risk of recurrent GI bleeding:

• H. pylori eradication in peptic ulcer disease reduces re-bleeding risk.
• Judicious use of NSAIDs and consideration of COX-2 inhibitors or PPI/misoprostol co-therapy for patients requiring NSAIDs.
• Lifestyle modifications, including increased physical activity, to prevent diverticular disease progression.
• Awareness of medications that increase bleeding risk (aspirin, NSAIDs).

Enhancing Healthcare Team Outcomes

Optimal care for GI bleeding necessitates coordinated interprofessional teamwork. Nurses play a critical role in monitoring and early detection of hemodynamic changes. Physicians (internists, critical care specialists, gastroenterologists, surgeons, radiologists) contribute specialized expertise in diagnosis and management. Pharmacists ensure appropriate medication use. Effective communication and collaboration among all team members are essential to improve patient outcomes and reduce morbidity and mortality in GI bleeding.

Review Questions

Figure: Sengstaken-Blakemore tube for esophageal variceal bleeding management.

Sengstaken–Blakemore tube Olek Remesz (wiki-pl: Orem, commons: Orem) [CC BY-SA 3.0 (https://creativecommons.org/licenses/by-sa/3.0)], from Wikimedia Commons

References

1.Lee YT, Walmsley RS, Leong RW, Sung JJ. Dieulafoy’s lesion. Gastrointest Endosc. 2003 Aug;58(2):236-43. [PubMed: 12872092]

2.Weston AP. Hiatal hernia with cameron ulcers and erosions. Gastrointest Endosc Clin N Am. 1996 Oct;6(4):671-9. [PubMed: 8899401]

3.Wuerth BA, Rockey DC. Changing Epidemiology of Upper Gastrointestinal Hemorrhage in the Last Decade: A Nationwide Analysis. Dig Dis Sci. 2018 May;63(5):1286-1293. [PubMed: 29282637]

4.Ghassemi KA, Jensen DM. Lower GI bleeding: epidemiology and management. Curr Gastroenterol Rep. 2013 Jul;15(7):333. [PMC free article: PMC3857214] [PubMed: 23737154]

5.Longstreth GF. Epidemiology of hospitalization for acute upper gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol. 1995 Feb;90(2):206-10. [PubMed: 7847286]

6.Lanas A, Perez-Aisa MA, Feu F, Ponce J, Saperas E, Santolaria S, Rodrigo L, Balanzo J, Bajador E, Almela P, Navarro JM, Carballo F, Castro M, Quintero E., Investigators of the Asociación Española de Gastroenterología (AEG). A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol. 2005 Aug;100(8):1685-93. [PubMed: 16086703]

7.Strate LL, Gralnek IM. ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding. Am J Gastroenterol. 2016 May;111(5):755. [PubMed: 27151132]

8.Dusold R, Burke K, Carpentier W, Dyck WP. The accuracy of technetium-99m-labeled red cell scintigraphy in localizing gastrointestinal bleeding. Am J Gastroenterol. 1994 Mar;89(3):345-8. [PubMed: 8122642]

9.Funaki B. Endovascular intervention for the treatment of acute arterial gastrointestinal hemorrhage. Gastroenterol Clin North Am. 2002 Sep;31(3):701-13. [PubMed: 12481726]

10.Walker TG. Acute gastrointestinal hemorrhage. Tech Vasc Interv Radiol. 2009 Jun;12(2):80-91. [PubMed: 19853226]

11.Oakland K, Jairath V, Uberoi R, Guy R, Ayaru L, Mortensen N, Murphy MF, Collins GS. Derivation and validation of a novel risk score for safe discharge after acute lower gastrointestinal bleeding: a modelling study. Lancet Gastroenterol Hepatol. 2017 Sep;2(9):635-643. [PubMed: 28651935]

12.Qaseem A, Humphrey LL, Fitterman N, Starkey M, Shekelle P., Clinical Guidelines Committee of the American College of Physicians. Treatment of anemia in patients with heart disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013 Dec 03;159(11):770-779. [PubMed: 24297193]

13.Duggan JM. Gastrointestinal hemorrhage: should we transfuse less? Dig Dis Sci. 2009 Aug;54(8):1662-6. [PubMed: 19034655]

14.Wynick D, Polak JM, Bloom SR. Somatostatin and its analogues in the therapy of gastrointestinal disease. Pharmacol Ther. 1989;41(1-2):353-70. [PubMed: 2565581]

15.Roberts SE, Button LA, Williams JG. Prognosis following upper gastrointestinal bleeding. PLoS One. 2012;7(12):e49507. [PMC free article: PMC3520969] [PubMed: 23251344]

16.Strate LL, Ayanian JZ, Kotler G, Syngal S. Risk factors for mortality in lower intestinal bleeding. Clin Gastroenterol Hepatol. 2008 Sep;6(9):1004-10; quiz 955-. [PMC free article: PMC2643270] [PubMed: 18558513]

17.Wilkins T, Embry K, George R. Diagnosis and management of acute diverticulitis. Am Fam Physician. 2013 May 01;87(9):612-20. [PubMed: 23668524]

Disclosure: Alexander DiGregorio declares no relevant financial relationships with ineligible companies.

Disclosure: Heidi Alvey declares no relevant financial relationships with ineligible companies.